Characterization of Microbial Components Present in Bioconcept Metalworking Fluid That May Contribute to the Development of Severe Lung Pathology
Public Domain
-
2024/02/01
-
Details
-
Personal Author:
-
Description:Rationale: Workers at a manufacturing facility using bioconcept metalworking fluid (MWF) engineered to selectively grow the biocontrol organism Pseudomonas pseudoalcaligenes developed a severe lung disease described as bronchiolitis, alveolar ductitis, and emphysema (BADE). Analysis of lung biopsies from affected workers indicated the lung microbiome was similar to that observed in used MWF. We hypothesized that this shift in the lung microbiome may contribute to the development of BADE. Methods: Pseudomonas species within used bioconcept MWF from the facility were isolated by viable culture. Bacterial 16S rRNA sequencing was conducted to ensure isolation of a single organism and to compare to P. pseudoalcaligenes strains (ATCC#17443 and ATCC#49536). Further characterization included quantification of microbial metabolites produced by the Pseudomonas isolates by liquid chromatography-tandem mass spectrometry. Results: Bacterial diversity within used MWF samples showed Pseudomonas sp. comprised 53.85% (Range: 0.07%-99.87%) of the total bacterial sequences. Two isolates were cultured and sequenced along with two P. pseudoalcaligenes strains. The 16S sequences of the isolates and ATCC strains clustered separately but were 96.6% similar, both matching deposited sequences for Pseudomonas sp. Microbial metabolites identified in all four Pseudomonas cultures included maculosin (11.2-15.4 µg/mL), cyclo(L-Pro-L-Val) (2.06-3.07 µg/mL), and brevianamide F (61.5-106 ng/mL), all of which are diketopiperazines. Conclusions: Diketopiperazines derived from microbes have known antimicrobial properties, many of which have been shown to modulate microbiome environments. High concentrations of diketopiperazines produced by Pseudomonas sp. may contribute to microbiome dysbiosis within the lungs of affected workers, which in turn may contribute to unique lung pathologies not seen in previous MWF exposures. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0091-6749
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:153
-
Issue:2
-
NIOSHTIC Number:nn:20070242
-
Citation:J Allergy Clin Immunol 2024 Feb; 153(2)(Suppl):AB246
-
Federal Fiscal Year:2024
-
Peer Reviewed:False
-
Source Full Name:Journal of Allergy and Clinical Immunology
-
Supplement:Suppl
-
Collection(s):
-
Main Document Checksum:urn:sha-512:6b9cc76f30769b99cf667f74e9d9415a88a4997cdde82966b3547aeb96caa570aae3a41e3efc1ab33d8f7244dad52e1bf7490e46e13672b41753ff5e54842b3c
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like